Question 1

What routes can Surovetmab be administered by?

Accepted Answer

Available routes: IV.

Question 2

Is Surovetmab a controlled substance?

Accepted Answer

Surovetmab is not federally scheduled in the US. Controlled-drug status differs by country — verify your local rules.

Question 3

What are the warnings or contraindications for Surovetmab?

Accepted Answer

Investigational/conditionally approved. Immune-mediated adverse events possible. Monitor for autoimmune-like reactions. Dogs only.

Question 4

What are the side effects of Surovetmab?

Accepted Answer

Reported side effects, adverse reactions, and contraindications for Surovetmab: Investigational/conditionally approved. Immune-mediated adverse events possible. Monitor for autoimmune-like reactions. Dogs only.

Question 5

How does Surovetmab work?

Accepted Answer

Anti-PD-L1 canine monoclonal antibody checkpoint inhibitor. Blocks PD-1/PD-L1 interaction to restore T-cell mediated anti-tumor immune response.

Surovetmab

Drug Class

Routes

Mechanism of Action

Side effects & warnings

Upgrade for Full Details